Complex Bacterial detection and enumeration made simple.

Rapidly detects bacteria when minutes
matter most.

Better answers to microbial contamination concerns equals better decisions. Better decisions equals better returns.

Accurate bacterial enumeration in very complex sample matrices.

Directly and accurately enumerates foodborne pathogens.

Vivione Biosciences Inc.

(CDNX symbol: VBI.H)

Publicly available information on the Company may be found on

Industry Thought Leaders Applying Vivione Biosciences Leading Edge Diagnostic Technologies to Critical Oil and Gas Operating Problems

Vivione Biosciences Announces Successful Field Deployment of RAPID-B with Greene's Energy

Vivione Biosciences Announces Preferred Vendor Arrangement With Ely and Associates

Vivione Biosciences Inc. Announces Agreement to Acquire Trillium Diagnostics

Vivione Biosciences Inc. Announces a Strategic Partnership with Sale of the RAPID-B system To AES Water Solutions

Vivione Biosciences Announces Successful Completion of Its Early-Stage Pilot Study at the Cleveland Clinic

Vivione Biosciences Engages Ardour Capital As Its Exclusive Investment Banker

Vivione Biosciences Inc. Receives AOAC Certification, Positions Brand for Fast Growth in Food Industry

Vivione Signs Strategic Alliance Agreement with IEH and Launches New Oil and Gas Product Offerings

Vivione Biosciences Inc. announces agreement with Litmus, LLC for Molecular Design Rights

Vivione Biosciences Inc. Enters Agreement with World’s Largest Public Relations Firm, Edelman

Vivione Biosciences Inc. receives coveted Letter of No Objection (LNO) designation from US Department

Vivione Biosciences signs agreement with CMS Technology

Vivione Biosciences Inc. chief executive officer interviewed by CEOCFO Magazine

Vivione Biosciences announces closing of the private placement offering with the arkansas venture capital